Celsion Corporation
(NASDAQ : CLSN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
2.04%83.500.6%$481.82m
ISRGIntuitive Surgical, Inc.
2.58%369.872.5%$367.36m
TMOThermo Fisher Scientific Inc.
2.10%192.281.0%$346.78m
ABTAbbott Laboratories
1.41%55.500.8%$338.63m
BSXBoston Scientific Corporation
0.59%25.771.1%$301.16m
ALGNAlign Technology, Inc.
-0.11%233.556.3%$282.50m
BDXBecton, Dickinson and Company
1.13%221.251.3%$266.30m
BCRC. R. Bard, Inc.
0.55%333.941.6%$202.72m
EWEdwards Lifesciences Corporation
-0.07%114.231.2%$193.50m
BAXBaxter International Inc.
0.83%65.321.7%$188.73m
SYKStryker Corporation
1.92%154.251.3%$182.70m
ZBHZimmer Biomet Holdings, Inc.
2.14%115.231.7%$146.86m
HOLXHologic, Inc.
1.33%43.531.7%$134.39m
COOCooper Companies, Inc.
2.00%229.352.2%$109.14m
XRAYDENTSPLY International Inc.
1.26%66.483.0%$106.34m

Company Profile

Celsion Corp. is an oncology drug development company. It focuses on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA- based therapies. The company's products include ThermoDox and GEN-1. Celsion was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.